Cooper Companies (COO) Price Target Increased to $306.00 by Analysts at BMO Capital Markets

Share on StockTwits

Cooper Companies (NYSE:COO) had its price objective raised by BMO Capital Markets from $294.00 to $306.00 in a research report released on Friday, The Fly reports. The brokerage currently has an outperform rating on the medical device company’s stock.

A number of other brokerages have also commented on COO. Oppenheimer set a $270.00 price objective on Cooper Companies and gave the company a hold rating in a report on Friday, August 31st. Raymond James increased their price objective on Cooper Companies from $270.00 to $300.00 and gave the company an outperform rating in a report on Friday, September 21st. KeyCorp lowered their price objective on Cooper Companies from $298.00 to $296.00 and set an overweight rating on the stock in a report on Friday. Zacks Investment Research lowered Cooper Companies from a buy rating to a hold rating in a report on Thursday, August 16th. Finally, ValuEngine raised Cooper Companies from a hold rating to a buy rating in a report on Thursday, September 27th. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus price target of $284.50.

Shares of NYSE COO traded down $34.02 during mid-day trading on Friday, reaching $243.01. 1,253,678 shares of the company traded hands, compared to its average volume of 333,174. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.54 and a current ratio of 2.58. The firm has a market cap of $13.61 billion, a price-to-earnings ratio of 21.13, a P/E/G ratio of 2.13 and a beta of 0.77. Cooper Companies has a fifty-two week low of $216.47 and a fifty-two week high of $283.18.

Cooper Companies (NYSE:COO) last issued its quarterly earnings data on Thursday, December 6th. The medical device company reported $2.87 EPS for the quarter, missing the Zacks’ consensus estimate of $2.96 by ($0.09). The company had revenue of $651.50 million for the quarter, compared to analyst estimates of $645.25 million. Cooper Companies had a net margin of 5.52% and a return on equity of 17.86%. The business’s revenue was up 16.0% on a year-over-year basis. During the same period in the prior year, the company posted $2.65 EPS. As a group, equities research analysts forecast that Cooper Companies will post 12.1 earnings per share for the current year.

In related news, Director A Thomas Bender sold 7,150 shares of the stock in a transaction that occurred on Monday, September 24th. The stock was sold at an average price of $269.36, for a total transaction of $1,925,924.00. Following the completion of the sale, the director now owns 18,355 shares in the company, valued at approximately $4,944,102.80. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Daniel G. Mcbride sold 10,310 shares of the stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $264.44, for a total value of $2,726,376.40. Following the sale, the chief operating officer now owns 38,705 shares of the company’s stock, valued at approximately $10,235,150.20. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 20,691 shares of company stock valued at $5,527,869. 1.60% of the stock is owned by corporate insiders.

Large investors have recently made changes to their positions in the stock. Resources Management Corp CT ADV bought a new stake in Cooper Companies during the 3rd quarter valued at approximately $203,000. Engineers Gate Manager LP bought a new stake in Cooper Companies during the 3rd quarter valued at approximately $208,000. Zeke Capital Advisors LLC bought a new stake in Cooper Companies during the 3rd quarter valued at approximately $209,000. Boston Private Wealth LLC bought a new stake in Cooper Companies during the 3rd quarter valued at approximately $213,000. Finally, Raymond James Trust N.A. bought a new stake in Cooper Companies during the 3rd quarter valued at approximately $214,000.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Recommended Story: What Is An Exchange-Traded Fund (ETF)?

The Fly

Analyst Recommendations for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.